{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:01:58Z","timestamp":1740157318933,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:00:00Z","timestamp":1435276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["19434"],"award-info":[{"award-number":["19434"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s40271-015-0130-3","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T07:22:59Z","timestamp":1435216979000},"page":"103-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Item Development and Face Validity of the Rheumatoid Arthritis Patient Priorities in Pharmacological Interventions Outcome Measures"],"prefix":"10.1007","volume":"9","author":[{"given":"Tessa","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Noddings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hewlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"issue":"41","key":"130_CR1","first-page":"86","volume":"21","author":"M Boers","year":"1994","unstructured":"Boers M, Tugwell P, Felson DT, van Reil PLCM, Kirwan JR, et al. World Health Organisation (WHO) and International League Against Rheumatism (ILAR) core endpoints for symptom-modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol. 1994;21(41):86\u20139.","journal-title":"J Rheumatol"},{"issue":"6","key":"130_CR2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","volume":"36","author":"D Felson","year":"1993","unstructured":"Felson D, Anderson J, Boers M. The American College of Rheumatology preliminary cores set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36(6):729\u201340.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"130_CR3","first-page":"579","volume":"20","author":"D Heijde Van der","year":"1993","unstructured":"Van der Heijde D, Hof M, Piet L, Putte L. Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol. 1993;20(3):579\u201381.","journal-title":"J Rheumatol"},{"issue":"4","key":"130_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/msc.1046","volume":"11","author":"T French","year":"2013","unstructured":"French T, Hewlett S, Kirwan J, Sanderson T. Different wording of the Patient Global Visual Analogue Scale (PG-VAS) affects rheumatoid arthritis patients\u2019 scoring and the overall Disease Activity Score (DAS28): a cross-sectional study. Musculoskeletal Care. 2013;11(4):229\u201337.","journal-title":"Musculoskeletal Care"},{"key":"130_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137\u201345.","journal-title":"Arthritis Rheum"},{"key":"130_CR6","unstructured":"NICE. Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis after failure of a TNF-alpha inhibitor. Appraisal consultation document. London: NICE; 2008."},{"key":"130_CR7","doi-asserted-by":"crossref","unstructured":"Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, Kostanjsek N, Schouten J. ICF core sets for rheumatoid arthritis. J Rehabil Med. 2004;Suppl(44):87-93.","DOI":"10.1080\/16501960410015470"},{"key":"130_CR8","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar1956","volume":"8","author":"M Coenen","year":"2006","unstructured":"Coenen M, Stamm T, Cieza A, Amann E, Kollerits B, Stucki G. Validation of the comprehensive ICF core set for rheumatoid arthritis from the patients\u2019 perspective using focus groups. Arthritis Res Ther. 2006;8:R84.","journal-title":"Arthritis Res Ther."},{"key":"130_CR9","first-page":"1174","volume":"34","author":"J Kirwan","year":"2007","unstructured":"Kirwan J, Minnock P, Adebajo A, Bresnihan B, Choy E, De Witt M, et al. Patient perspective workshop: fatigue as a recommended patient-centred outcome measure in rheumatoid arthritis. J Rheumatol. 2007;34:1174\u201382.","journal-title":"J Rheumatol"},{"key":"130_CR10","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures. Use in medical product development to support labeling claims; 2009. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf . Accessed 4 Jan 2014."},{"key":"130_CR11","first-page":"1528","volume":"35","author":"L Linde","year":"2008","unstructured":"Linde L, Sorensen J, Ostergaard M, Horslev-Pedersen K, Lund Hetland M. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol. 2008;35:1528\u201337.","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"130_CR12","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","volume":"10","author":"DL Patrick","year":"2007","unstructured":"Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10(Suppl 2):S125\u201337.","journal-title":"Value Health"},{"key":"130_CR13","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1111\/j.1524-4733.2007.00272.x","volume":"2","author":"MF Frost","year":"2007","unstructured":"Frost MF, Reeve BB, Liepa AM, Stauffer JW, Hays RD. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. 2007;2:S94\u2013105.","journal-title":"Value Health"},{"issue":"4","key":"130_CR14","first-page":"877","volume":"30","author":"S Hewlett","year":"2003","unstructured":"Hewlett S. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol. 2003;30(4):877\u20139.","journal-title":"J Rheumatol"},{"issue":"3","key":"130_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/msc.3","volume":"3","author":"S Hewlett","year":"2005","unstructured":"Hewlett S, Carr M, Ryan S, Kirwan J, Richards P, Carr A, et al. Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care. 2005;3(3):131\u201342.","journal-title":"Musculoskeletal Care"},{"key":"130_CR16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.2010.142901","volume":"70","author":"L Gossec","year":"2011","unstructured":"Gossec L, Patternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis. 2011;70:935\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"130_CR17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.20034","volume":"62","author":"T Sanderson","year":"2010","unstructured":"Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. What outcomes from pharmacological treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care Res. 2010;62(5):640\u20136.","journal-title":"Arthritis Care Res"},{"key":"130_CR18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/rheumatology\/keh237","volume":"43","author":"NJ Marshall","year":"2004","unstructured":"Marshall NJ, Wilson G, Lapworth K, Kay LJ. Patients\u2019 perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study. Rheumatology. 2004;43:1034\u20138.","journal-title":"Rheumatology"},{"issue":"1","key":"130_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/rheumatology\/keh412","volume":"44","author":"M Ahlmen","year":"2005","unstructured":"Ahlmen M, Nordenskiold U, Archenholtz B, Thyberg I, Ronnqvist R, Linden L, et al. Rheumatology outcomes: the patient\u2019s perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology. 2005;44(1):105\u201310.","journal-title":"Rheumatology"},{"issue":"5","key":"130_CR20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/acr.20151","volume":"62","author":"T Sanderson","year":"2010","unstructured":"Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the Rheumatoid Arthritis Patient Priorities for Pharmacological Interventions (RAPP-PI) outcomes. Arthritis Care Res. 2010;62(5):647\u201356.","journal-title":"Arthritis Care Res"},{"key":"130_CR21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","volume":"67","author":"M Boers","year":"2014","unstructured":"Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, D\u2019agostino M-A, et al. Developing core outcome measurement sets for clinical trials: OMERACT Filter 2.0. J Clin Epidemiol. 2014;67:745\u201353.","journal-title":"J Clin Epidemiol"},{"key":"130_CR22","unstructured":"Sanderson T. Well-being and the prioritisation of treatment outcomes in rheumatoid arthritis. Doctoral thesis; 2009."},{"key":"130_CR23","unstructured":"Sanderson T, Kirwan J, Almeida C, Morris M, Watts A, Noddings R, Hewlett S. Feasibility, and preliminary validity and sensitivity of the Rheumatoid Arthritis Patient Priorities in Pharmacological Interventions (RAPP-PI) outcome measures (awaiting submission)."},{"key":"130_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJF, Cooper NS, Healey LA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"130_CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002508-200407000-00002","volume":"20","author":"KA Herr","year":"2004","unstructured":"Herr KA, Spratt K, Mobily PR, Richardson G. Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain. 2004;20(4):207\u201319.","journal-title":"Clin J Pain"},{"key":"130_CR26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1529-0131(200108)45:4<317::AID-ART343>3.0.CO;2-X","volume":"45","author":"D Anderson","year":"2001","unstructured":"Anderson D. Development of an instrument to measure pain in rheumatoid arthritis: Rheumatoid Arthritis Pain Scale (RAPS). Arthritis Care Res. 2001;45:317\u201323.","journal-title":"Arthritis Care Res"},{"key":"130_CR27","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","volume":"42","author":"T Pincus","year":"1999","unstructured":"Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum. 1999;42:2220\u201330.","journal-title":"Arthritis Rheum"},{"key":"130_CR28","first-page":"1261","volume":"32","author":"F Wolfe","year":"2005","unstructured":"Wolfe F, Michaud K, Pincus T. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis. J Rheumatol. 2005;32:1261\u20136.","journal-title":"J Rheumatol"},{"key":"130_CR29","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833\u201340.","journal-title":"J Rheumatol"},{"key":"130_CR30","unstructured":"WHOQOL. The World Health Organisation Quality of Life (WHOQOL)-BREF UK version. WHO: Geneva; 2004."},{"key":"130_CR31","unstructured":"WHOQOL. The World Health Organisation Quality of Life (WHOQOL)\u2014100. WHO: Geneva; 1995."},{"key":"130_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780350102","volume":"35","author":"RF Meenan","year":"1992","unstructured":"Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales health status questionnaire. Arthritis Rheum. 1992;35:1\u201310.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"130_CR33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","volume":"49","author":"E Diener","year":"1985","unstructured":"Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. 1985;49(1):71\u20135.","journal-title":"J Pers Assess."},{"issue":"3","key":"130_CR34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00006199-200005000-00002","volume":"49","author":"AK Stuifbergen","year":"2000","unstructured":"Stuifbergen AK, Seraphine A, Roberts G. An explanatory model of health promotion and quality of life in chronic disabling conditions. Nurs Res. 2000;49(3):122\u20139.","journal-title":"Nurs Res"},{"key":"130_CR35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/rheumatology\/36.8.878","volume":"36","author":"Z Jong de","year":"1997","unstructured":"de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol. 1997;36:878\u201383.","journal-title":"Br J Rheumatol"},{"key":"130_CR36","first-page":"462","volume":"12","author":"PM Nicassio","year":"1985","unstructured":"Nicassio PM, Wallston KA, Callahan LF, Herbert M, Pincus P. The measurement of helplessness in rheumatoid arthritis: the development of the Arthritis Helplessness Index. J Rheumatol. 1985;12:462\u20137.","journal-title":"J Rheumatol"},{"issue":"11","key":"130_CR37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/acr.20282","volume":"62","author":"J Nicklin","year":"2010","unstructured":"Nicklin J, Cramp F, Kirwan J, Greenwood R, Urban M, Hewlett S. Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales. Arthritis Care Res. 2010;62(11):1559\u201368.","journal-title":"Arthritis Care Res"},{"issue":"12","key":"130_CR38","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.3899\/jrheum.080375","volume":"35","author":"D Khanna","year":"2008","unstructured":"Khanna D, Pope JE, Khanna PP, Maloney M, Samedi N, Norrie D, Ouimet G, Hays R. The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rheumatol. 2008;35(12):2335\u201343.","journal-title":"J Rheumatol"},{"issue":"10","key":"130_CR39","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/kel066","volume":"45","author":"R Westhovens","year":"2006","unstructured":"Westhovens R, Bole JC, Li T, Martin M, MacLean R, Lin P, Blaisdell B, Wallenstein GV, Aranda R, Sherrer Y. Improved health-related quality of life for rheumatoid arthritis patients treated with abatercept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial. Rheumatology. 2006;45(10):1238\u201346.","journal-title":"Rheumatology"},{"key":"130_CR40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NMB, O\u2019Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160\u20134.","journal-title":"BMJ"},{"issue":"4","key":"130_CR41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2190\/5DCP-25BV-U1G9-9G7C","volume":"13","author":"GM Devins","year":"1983","unstructured":"Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barr\u00e9 PE, Guttmann RD. The emotional impact of end-stage renal disease: importance of patients\u2019 perceptions of intrusiveness and control. Int J Psychiatry Med. 1983;13(4):327\u201343.","journal-title":"Int J Psychiatry Med"},{"issue":"12","key":"130_CR42","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/acr.20617","volume":"63","author":"PP Katz","year":"2011","unstructured":"Katz PP, Radvanski DC, Allen D, Buyske S, Schiff S, Nadkarni A, Rosenblatt L, Maclean R, Hassett AL. Development and validation of a short form of the valued life activities disability questionnaire for rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011;63(12):1664\u201371.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"2","key":"130_CR43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nedt.2003.10.001","volume":"24","author":"UH Graneheim","year":"2004","unstructured":"Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105\u201312.","journal-title":"Nurse Educ Today"},{"issue":"11","key":"130_CR44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/acr.20264","volume":"62","author":"J Nicklin","year":"2010","unstructured":"Nicklin J, Cramp F, Kirwan J, Urban M, Hewlett S. Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res. 2010;62(11):1552\u20138.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"130_CR45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3899\/jrheum.100700","volume":"38","author":"T Sanderson","year":"2011","unstructured":"Sanderson T, Hewlett S, Flurey C, Dures E, Richards P, Kirwan J. The impact triad (severity, importance and self-management) as a method of enhancing the measurement of the personal life impact of rheumatic diseases (Editorial). J Rheumatol. 2011;38(2):191\u20134.","journal-title":"J Rheumatol"},{"issue":"2","key":"130_CR46","first-page":"229","volume":"12","author":"D Collins","year":"2008","unstructured":"Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2008;12(2):229\u201338.","journal-title":"Qual Life Res"},{"key":"130_CR47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/art.22091","volume":"55","author":"S Hewlett","year":"2006","unstructured":"Hewlett S, Wit M, Richards P, Quest E, Hughes R, Heiberg T, Kirwan J. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Rheum. 2006;55:676\u201380.","journal-title":"Arthritis Rheum"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-015-0130-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40271-015-0130-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-015-0130-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T14:15:14Z","timestamp":1566915314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40271-015-0130-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s40271-015-0130-3","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"type":"print","value":"1178-1653"},{"type":"electronic","value":"1178-1661"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}